Wave Life Sciences (WVE) Depreciation & Amortization (CF) (2016 - 2026)
Wave Life Sciences (WVE) has disclosed Depreciation & Amortization (CF) for 12 consecutive years, with $841000.0 as the latest value for Q1 2026.
- For Q1 2026, Depreciation & Amortization (CF) fell 3.89% year-over-year to $841000.0; the TTM value through Mar 2026 reached $3.4 million, down 9.73%, while the annual FY2025 figure was $3.4 million, 12.73% down from the prior year.
- Depreciation & Amortization (CF) hit $841000.0 in Q1 2026 for Wave Life Sciences, up from $804000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $1.7 million in Q1 2022 and bottomed at $804000.0 in Q4 2025.
- Average Depreciation & Amortization (CF) over 5 years is $1.2 million, with a median of $1.0 million recorded in 2024.
- Year-over-year, Depreciation & Amortization (CF) fell 29.71% in 2023 and then decreased 3.89% in 2026.
- Wave Life Sciences' Depreciation & Amortization (CF) stood at $1.5 million in 2022, then dropped by 29.71% to $1.1 million in 2023, then decreased by 16.1% to $907000.0 in 2024, then fell by 11.36% to $804000.0 in 2025, then increased by 4.6% to $841000.0 in 2026.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods came in at $841000.0, $804000.0, and $856000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.